Cancer blood test maker Freenome going public with $330M SPAC
Article Title: Cancer blood test maker Freenome going public with $330M SPAC Publication Date: December 5, 2025 Freenome Holdings Inc., the manufacturer of cancer blood tests, has announced its plans to go public via a special purpose acquisition company (SPAC),…